URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Ann Falsey

Concepts (303)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Respiratory Syncytial Virus Infections
36
1995
127
11.260
Why?
Respiratory Tract Infections
22
1990
159
6.640
Why?
Antibodies, Viral
25
1990
472
4.960
Why?
Respiratory Syncytial Virus, Human
16
1997
53
4.930
Why?
Metapneumovirus
10
2003
21
4.670
Why?
Paramyxoviridae Infections
12
1991
37
4.660
Why?
Influenza, Human
18
1995
350
4.320
Why?
Respiratory Syncytial Viruses
21
1990
128
4.290
Why?
Virus Diseases
9
1991
83
4.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
18
2001
542
3.800
Why?
Aged
66
1990
7269
2.770
Why?
Aged, 80 and over
36
1992
2529
2.180
Why?
Pulmonary Disease, Chronic Obstructive
6
2005
102
2.060
Why?
Influenza Vaccines
6
2007
264
1.960
Why?
Nasal Mucosa
8
1999
56
1.930
Why?
Antigens, Viral
10
1995
149
1.910
Why?
Influenza A virus
9
1999
225
1.820
Why?
Molecular Diagnostic Techniques
3
2010
11
1.820
Why?
Sputum
3
2007
57
1.770
Why?
Antiviral Agents
7
1996
175
1.720
Why?
Viruses
4
1992
27
1.700
Why?
Humans
88
1990
36274
1.680
Why?
Virology
2
2011
22
1.630
Why?
Adult
43
1997
11351
1.490
Why?
Nursing Homes
9
1990
199
1.490
Why?
Hospitalization
10
1995
399
1.410
Why?
Pneumonia, Viral
4
2005
27
1.400
Why?
Immunoenzyme Techniques
8
1990
220
1.390
Why?
Middle Aged
36
1990
9837
1.360
Why?
Neutralization Tests
7
1997
129
1.320
Why?
Specimen Handling
3
1999
71
1.290
Why?
Viral Vaccines
7
1996
109
1.280
Why?
Male
46
1992
19675
1.260
Why?
Female
47
1990
19838
1.260
Why?
Antibodies, Neutralizing
4
2009
32
1.220
Why?
Respiratory Syncytial Virus Vaccines
4
2007
13
1.140
Why?
HN Protein
4
1998
37
1.060
Why?
Sensitivity and Specificity
11
1996
905
1.000
Why?
Coronavirus Infections
4
1999
17
0.980
Why?
Disease Outbreaks
2
2003
117
0.960
Why?
Prospective Studies
16
1992
1689
0.950
Why?
Inpatients
4
2002
72
0.910
Why?
Immunoglobulin G
12
1997
488
0.900
Why?
Day Care
3
1995
14
0.890
Why?
Coronavirus
3
1997
12
0.880
Why?
Viral Envelope Proteins
6
1998
89
0.860
Why?
Respiratory Insufficiency
2
2008
58
0.840
Why?
Calcitonin
1
2012
42
0.820
Why?
Pneumonia, Bacterial
1
2012
17
0.820
Why?
Homes for the Aged
6
1992
63
0.800
Why?
Protein Precursors
1
2012
84
0.790
Why?
Immunity, Humoral
2
2009
18
0.750
Why?
Respiratory Tract Diseases
2
2010
45
0.750
Why?
Bacterial Infections
1
2012
130
0.750
Why?
Viral Proteins
6
1998
214
0.740
Why?
Immunization
2
2001
175
0.710
Why?
Drug Delivery Systems
1
2010
59
0.710
Why?
Glucocorticoids
1
2011
162
0.700
Why?
Pneumonia
1
2012
196
0.700
Why?
RNA, Viral
4
2001
275
0.700
Why?
Frail Elderly
5
1995
66
0.690
Why?
Alum Compounds
1
2008
5
0.670
Why?
New York
9
1990
1305
0.660
Why?
Nasopharynx
3
1997
48
0.630
Why?
Influenza B virus
1
2007
43
0.560
Why?
Antibody-Producing Cells
3
2010
35
0.560
Why?
Seasons
7
1990
97
0.550
Why?
Rhinovirus
4
1991
20
0.550
Why?
Risk Factors
7
1992
2345
0.520
Why?
DNA, Viral
1
2007
292
0.520
Why?
Common Cold
2
1999
12
0.510
Why?
Diagnosis, Differential
4
2003
874
0.480
Why?
Vaccination
6
1996
232
0.470
Why?
Virus Shedding
1
2003
10
0.460
Why?
Viral Load
3
2003
135
0.460
Why?
Immunoglobulin A, Secretory
2
1999
23
0.460
Why?
HSP90 Heat-Shock Proteins
1
2003
18
0.460
Why?
Severe Acute Respiratory Syndrome
1
2003
6
0.450
Why?
Heart Failure
2
1999
367
0.450
Why?
C-Reactive Protein
2
2001
122
0.440
Why?
Respirovirus Infections
3
1990
66
0.430
Why?
Long-Term Care
3
2005
64
0.430
Why?
Cholecystitis
1
2002
8
0.430
Why?
Aging
3
1999
707
0.430
Why?
Stress, Physiological
1
2003
107
0.420
Why?
Immunoglobulin A
3
2000
90
0.400
Why?
Interferon-gamma
3
2005
348
0.400
Why?
Nose
3
1996
50
0.400
Why?
Staphylococcal Infections
1
2002
107
0.400
Why?
Staphylococcus aureus
1
2002
108
0.390
Why?
Double-Blind Method
5
1996
992
0.390
Why?
Apolipoproteins
1
2001
41
0.390
Why?
Antibody Formation
4
1992
179
0.380
Why?
Cross Infection
3
1991
88
0.380
Why?
Heart Diseases
3
2002
142
0.370
Why?
Vaccines, Synthetic
2
1997
90
0.370
Why?
Cohort Studies
5
1995
969
0.360
Why?
Vaccines, Attenuated
1
2000
86
0.360
Why?
Lung Diseases
3
2002
228
0.350
Why?
Pharynx
2
2007
41
0.350
Why?
Infection Control
1
1999
23
0.330
Why?
Adolescent
7
1999
4766
0.320
Why?
Logistic Models
2
2009
611
0.320
Why?
Age Factors
5
1999
1128
0.310
Why?
Young Adult
4
2008
1059
0.310
Why?
Disease Progression
2
2008
521
0.310
Why?
Acute Disease
7
1992
586
0.300
Why?
Interleukin-10
2
2005
104
0.300
Why?
Coronavirus 229E, Human
1
1997
4
0.300
Why?
Immunologic Memory
2
2005
119
0.300
Why?
Predictive Value of Tests
2
2007
606
0.300
Why?
Immunity, Mucosal
3
1999
25
0.300
Why?
Virus Cultivation
2
2003
30
0.300
Why?
Incidence
5
1990
685
0.300
Why?
Chlamydophila pneumoniae
2
1993
10
0.290
Why?
Time Factors
4
2002
3182
0.290
Why?
Fluorescent Antibody Technique, Indirect
2
1996
45
0.290
Why?
Leukocytes, Mononuclear
3
2002
110
0.280
Why?
Severity of Illness Index
4
2007
922
0.280
Why?
Child, Preschool
4
1991
2660
0.270
Why?
Biological Markers
3
2001
560
0.260
Why?
Dose-Response Relationship, Immunologic
2
2000
60
0.260
Why?
Respirovirus
2
2004
11
0.260
Why?
Asthma
2
2007
317
0.260
Why?
Immunocompromised Host
2
2000
83
0.240
Why?
Treatment Outcome
3
1995
2615
0.230
Why?
Chlamydia Infections
1
1993
21
0.230
Why?
Cytokines
2
2002
565
0.230
Why?
United States
4
2005
2688
0.220
Why?
Panax
1
2012
1
0.210
Why?
Child
3
2006
4155
0.200
Why?
Plant Extracts
1
2012
23
0.200
Why?
National Institute on Aging (U.S.)
1
2011
1
0.200
Why?
Clinical Trials as Topic
2
1998
671
0.200
Why?
T-Lymphocyte Subsets
2
1999
112
0.200
Why?
Croatia
2
2006
3
0.200
Why?
Skilled Nursing Facilities
1
1991
20
0.200
Why?
CD4-Positive T-Lymphocytes
3
1999
303
0.200
Why?
Bystander Effect
1
2011
3
0.200
Why?
Multivariate Analysis
2
2001
541
0.200
Why?
Adaptive Immunity
1
2011
8
0.200
Why?
Sendai virus
1
2011
19
0.200
Why?
Viral Fusion Proteins
2
1997
39
0.190
Why?
Chronic Disease
3
1997
522
0.190
Why?
Injections, Intradermal
1
2010
15
0.190
Why?
AIDS Vaccines
1
2011
68
0.190
Why?
Granzymes
1
2010
2
0.190
Why?
Infant
4
1991
2278
0.190
Why?
Injections, Intramuscular
1
2010
71
0.190
Why?
Statistics, Nonparametric
1
2011
262
0.180
Why?
Fasciitis
1
1990
11
0.180
Why?
Epitope Mapping
1
2010
28
0.180
Why?
Aspergillosis
1
1990
17
0.180
Why?
Evaluation Studies as Topic
2
1996
245
0.180
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2012
127
0.180
Why?
Outpatients
1
2009
33
0.180
Why?
Up-Regulation
1
2012
363
0.180
Why?
Retrospective Studies
2
2005
2267
0.180
Why?
Surgical Wound Infection
1
1990
57
0.170
Why?
Biomedical Research
1
2011
139
0.170
Why?
Epitopes
1
2010
202
0.170
Why?
Ribavirin
2
1996
45
0.160
Why?
Boston
1
2008
13
0.160
Why?
Flow Cytometry
1
2011
603
0.160
Why?
Phylogeny
1
2008
117
0.160
Why?
Length of Stay
2
1995
287
0.150
Why?
Community-Acquired Infections
1
2007
27
0.150
Why?
Risk Assessment
1
2012
884
0.150
Why?
Morbidity
1
2007
75
0.150
Why?
Communicable Disease Control
1
2007
27
0.150
Why?
Fever
2
2002
111
0.150
Why?
Communicable Diseases
1
2007
23
0.150
Why?
Anti-Bacterial Agents
2
2007
437
0.140
Why?
World Health
1
2007
63
0.140
Why?
Genotype
1
2008
490
0.140
Why?
Cell Culture Techniques
2
2003
92
0.140
Why?
Health Services for the Aged
1
2007
62
0.140
Why?
Infant, Newborn
2
2006
1844
0.140
Why?
Tumor Suppressor Protein p53
1
2007
138
0.140
Why?
Orthomyxoviridae
1
2006
58
0.130
Why?
Residence Characteristics
1
2005
68
0.130
Why?
Health Services
1
2005
66
0.120
Why?
Enzyme-Linked Immunosorbent Assay
2
1999
462
0.120
Why?
Seroepidemiologic Studies
2
1998
14
0.120
Why?
Cell Nucleus
1
2007
482
0.110
Why?
Protein S
1
2003
6
0.110
Why?
Hong Kong
1
2003
23
0.110
Why?
Causality
1
2003
45
0.110
Why?
Fluorescent Antibody Technique
1
2003
283
0.110
Why?
World Health Organization
1
2003
42
0.110
Why?
Gallbladder
1
2002
17
0.110
Why?
Cough
1
2002
22
0.110
Why?
Rimantadine
1
2002
10
0.100
Why?
Zanamivir
1
2002
13
0.100
Why?
Oseltamivir
1
2002
10
0.100
Why?
Pyrans
1
2002
14
0.100
Why?
Amantadine
1
2002
22
0.100
Why?
Guanidines
1
2002
31
0.100
Why?
Acetamides
1
2002
32
0.100
Why?
Sialic Acids
1
2002
33
0.100
Why?
Regression Analysis
2
2000
527
0.100
Why?
Glycoproteins
1
2003
201
0.100
Why?
Drug Resistance, Viral
1
2002
66
0.100
Why?
Convalescence
1
2001
19
0.100
Why?
Serum Amyloid A Protein
1
2001
23
0.100
Why?
Thrombophilia
1
2001
13
0.100
Why?
Animals
4
1993
16093
0.100
Why?
Hemostatics
1
2001
23
0.100
Why?
Hepatitis B Vaccines
1
2001
26
0.090
Why?
Cells, Cultured
3
1998
2479
0.090
Why?
Follow-Up Studies
1
2005
1855
0.090
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2001
81
0.090
Why?
Hemagglutination Inhibition Tests
2
2010
75
0.090
Why?
Adjuvants, Immunologic
1
2001
117
0.090
Why?
Lung Diseases, Obstructive
1
1999
40
0.090
Why?
Antibody Specificity
1
1999
106
0.090
Why?
Practice Guidelines as Topic
1
2002
302
0.080
Why?
Drug Administration Schedule
1
2000
366
0.080
Why?
Cytomegalovirus
1
1999
79
0.080
Why?
Cytomegalovirus Infections
1
1999
76
0.080
Why?
Antineoplastic Agents
1
2003
619
0.080
Why?
Prevalence
2
1990
562
0.070
Why?
Picornaviridae Infections
2
1991
13
0.070
Why?
Safety
1
1997
101
0.070
Why?
Analysis of Variance
1
1999
736
0.070
Why?
Cross-Sectional Studies
1
1999
654
0.070
Why?
Risk
1
1998
368
0.070
Why?
Health Personnel
1
1997
59
0.070
Why?
Neoplasms
1
2003
739
0.070
Why?
Serologic Tests
1
1996
24
0.070
Why?
Cell Line
2
1993
1585
0.070
Why?
Reproducibility of Results
1
1999
877
0.070
Why?
Enterovirus
1
1995
24
0.060
Why?
Allied Health Personnel
1
1995
16
0.060
Why?
T-Lymphocytes
1
1999
550
0.060
Why?
Confidence Intervals
2
1999
165
0.060
Why?
Environmental Microbiology
1
1993
3
0.060
Why?
Aerosols
1
1993
115
0.060
Why?
Coronaviridae Infections
1
1991
1
0.050
Why?
Adenovirus Infections, Human
1
1991
8
0.050
Why?
Disease Susceptibility
1
1992
79
0.050
Why?
Amino Acid Sequence
2
1998
1195
0.050
Why?
Africa
1
2011
9
0.050
Why?
Psychology
1
2011
37
0.050
Why?
Japan
1
2011
30
0.050
Why?
Sickness Impact Profile
1
2011
41
0.050
Why?
Immunity
1
1992
66
0.050
Why?
Parainfluenza Virus 1, Human
1
2011
37
0.050
Why?
Europe
1
2011
80
0.050
Why?
Cross Reactions
1
2011
108
0.050
Why?
Age of Onset
1
2011
126
0.050
Why?
Enzyme-Linked Immunospot Assay
1
2010
5
0.050
Why?
Fibrinogen
2
2001
149
0.050
Why?
Skin
1
1993
377
0.050
Why?
Hep G2 Cells
1
2010
9
0.050
Why?
Population Surveillance
1
2011
136
0.050
Why?
Immune System
1
2011
71
0.050
Why?
CD8-Positive T-Lymphocytes
2
1999
224
0.050
Why?
Kinetics
1
1993
1391
0.050
Why?
Debridement
1
1990
22
0.040
Why?
Immunity, Cellular
1
2010
132
0.040
Why?
Molecular Sequence Data
2
1998
1988
0.040
Why?
Influenza A Virus, H3N2 Subtype
1
2010
62
0.040
Why?
Necrosis
1
1990
103
0.040
Why?
Case-Control Studies
2
2001
617
0.040
Why?
Comorbidity
1
2011
380
0.040
Why?
Odds Ratio
1
2010
315
0.040
Why?
Genetic Vectors
1
2011
339
0.040
Why?
Diabetes Mellitus, Type 1
1
1990
166
0.040
Why?
Phenotype
1
2011
763
0.040
Why?
Antigens, Polyomavirus Transforming
1
2007
22
0.040
Why?
Nuclear Localization Signals
1
2007
18
0.040
Why?
beta Karyopherins
1
2007
14
0.040
Why?
Interleukin-5
1
2007
42
0.040
Why?
Phytohemagglutinins
1
2007
54
0.040
Why?
Pilot Projects
1
2008
442
0.040
Why?
Cytosol
1
2007
192
0.040
Why?
B-Lymphocytes
1
2010
432
0.040
Why?
Active Transport, Cell Nucleus
1
2007
96
0.040
Why?
Interleukin-4
1
2007
163
0.030
Why?
Polymerase Chain Reaction
1
2007
596
0.030
Why?
Administration, Intranasal
1
2004
61
0.030
Why?
Complement Inactivator Proteins
1
2003
14
0.030
Why?
Hemostasis
1
2003
62
0.030
Why?
Mice
1
1993
6111
0.030
Why?
Matched-Pair Analysis
1
2001
17
0.020
Why?
Hepatitis B Antibodies
1
2001
11
0.020
Why?
Fibrin Fibrinogen Degradation Products
1
2001
50
0.020
Why?
Dendritic Cells
1
2002
121
0.020
Why?
Interleukin-6
1
2003
339
0.020
Why?
Antigens, CD56
1
1999
16
0.020
Why?
Antigens, CD45
1
1999
37
0.020
Why?
HLA-DR Antigens
1
1999
55
0.020
Why?
Antigens, CD28
1
1999
35
0.020
Why?
Sex Factors
1
2001
597
0.020
Why?
Attachment Sites, Microbiological
1
1998
5
0.020
Why?
Disease Transmission, Infectious
1
1996
13
0.020
Why?
Blotting, Western
1
1998
645
0.020
Why?
Tumor Cells, Cultured
1
1998
881
0.020
Why?
Recurrence
1
1996
691
0.020
Why?
Antibodies, Monoclonal
1
1998
711
0.010
Why?
Base Sequence
1
1998
1683
0.010
Why?
Mutation
1
1998
1216
0.010
Why?

Visualizations


Falsey's Networks

Concepts
_
Co-Authors
_
Same Department